Pettenati C

References (4)

Title : Rivastigmine in Alzheimer's disease: Cognitive function and quality of life - Annicchiarico_2007_Ther.Clin.Risk.Manag_3_1113
Author(s) : Annicchiarico R , Federici A , Pettenati C , Caltagirone C
Ref : Ther Clin Risk Manag , 3 :1113 , 2007
Abstract :
PubMedSearch : Annicchiarico_2007_Ther.Clin.Risk.Manag_3_1113
PubMedID: 18516265

Title : Serum cholesterol levels modulate long-term efficacy of cholinesterase inhibitors in Alzheimer disease - Borroni_2003_Neurosci.Lett_343_213
Author(s) : Borroni B , Pettenati C , Bordonali T , Akkawi N , Di Luca M , Padovani A
Ref : Neuroscience Letters , 343 :213 , 2003
Abstract :
PubMedSearch : Borroni_2003_Neurosci.Lett_343_213
PubMedID: 12770699

Title : Clinical pharmacology of anti-Alzheimer drugs - Pettenati_2003_Fundam.Clin.Pharmacol_17_659
Author(s) : Pettenati C , Annicchiarico R , Caltagirone C
Ref : Fundamental & Clinical Toxicology , 17 :659 , 2003
Abstract :
PubMedSearch : Pettenati_2003_Fundam.Clin.Pharmacol_17_659
PubMedID: 15015711

Title : Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment - Borroni_2001_Arch.Neurol_58_442
Author(s) : Borroni B , Colciaghi F , Pastorino L , Pettenati C , Cottini E , Rozzini L , Monastero R , Lenzi GL , Cattabeni F , Di Luca M , Padovani A
Ref : Archives of Neurology , 58 :442 , 2001
Abstract :
PubMedSearch : Borroni_2001_Arch.Neurol_58_442
PubMedID: 11255448